Mississippi Administrative Code › Title 30 - Professions and Occupations › Part 2640 - Rules Pertaining to Prescribing, Administering, and Dispensing Medication › Chapter 1 - Rules Pertaining to Prescribing, Administering and Dispensing of Medication › Rule 30-2640-1.3 - Registration for Controlled Substances Certificate

Current through June 25, 2024
Every licensee who prescribes, administers or dispenses any
				  controlled substance within Mississippi or who proposes to engage in the
				  prescribing, administering or dispensing of any controlled substance within
				  Mississippi must be registered with the U.S. Drug Enforcement Administration in
				  compliance with Title 21 CFR Part 1301 Food and Drugs.
Each individual who is licensed by the Mississippi State
				  Board of Medical Licensure and has prescriptive authority must be registered
				  with the Mississippi Prescription Monitoring Program (MPMP). Every licensee who
				  provides medical care in a pain management practice as defined in Rule
				  1.2(K)
				   must review the MPMP at each patient
				  encounter in which a prescription for a controlled substance is issued. Every
				  licensee, regardless of practice specialty, must review the MPMP at each
				  patient encounter in which an opioid is prescribed for acute and/or chronic
				  non-cancerous/non-terminal pain. Those licensees whose practice is not a pain
				  management practice as defined previously must actively utilize the MPMP upon
				  initial contact with new patients and at least every three (3) months
				  thereafter on any and all patients who are prescribed, administered, or
				  dispensed controlled substances other than opioids. Licensees who issue a
				  prescription for Lomotil, Lyrica, Testosterone, Pseudoephedrine, or
				  Amphetamines prescribed to pediatric patients under the age of sixteen (16) for
				  the treatment of ADHD, are not required in that instance to utilize the MPMP as
				  stated herein.
Reports generated on such patients should span the length of
				  time from the previous review of the MPMP so that adequate information is
				  obtained to determine patient compliance with treatment. Documentation, such as
				  a copy of the report itself and/or reflection in the chart dictation and/or
				  notes, must be kept within the patient's record and made available for
				  inspection upon request. As allowed by the Mississippi Board of Pharmacy and
				  the MPMP, properly registered designees of the licensee may run/obtain the
				  report for the licensee's review as required herein.
Utilization of the MPMP as stated herein is not required
				  when treating inpatient; however, upon discharge from said inpatient setting
				  with a prescription for a controlled substance, the MPMP must be reviewed as
				  required herein.
Pursuant to authority granted in Mississippi Code, Section
				  41-29-125,
				  the Mississippi State Board of Medical Licensure hereby adopts, in lieu of a
				  separate registration with the Board, the registration with the U.S. Drug
				  Enforcement Administration as required in the above paragraph. In the event,
				  however, a licensee has had limitations or other restrictions placed upon his
				  or her license wherein he or she is prohibited from ordering, dispensing, or
				  prescribing controlled substances in any schedule, said licensee shall be
				  prohibited from registering with the U.S. Drug Enforcement Administration for a
				  Uniform Controlled Substances Registration Certificate without first being
				  expressly authorized to do so by order of the Mississippi State Board of
				  Medical Licensure.
Persons registered to prescribe, administer, dispense or
				  conduct research with controlled substances may order, possess, prescribe,
				  administer, dispense or conduct research with those substances to the extent
				  authorized by their registration and in conformity with the other provisions of
				  these rules and in conformity with provisions of the Mississippi Uniform
				  Controlled Substances Law, Mississippi Code Section
				  41-29-101 et
				  seq.
The registration requirement set forth in these rules does
				  not apply to the distribution and manufacture of controlled substances. Any
				  licensee who engages in the manufacture or distribution of controlled
				  substances or legend drugs must register with the Mississippi State Board of
				  Pharmacy pursuant to Mississippi Code, Section
				  73-21-105
				  and will be subject to all applicable federal statutes and regulations
				  controlling such practices. For the purposes herein, "distribute" means the
				  delivery of a drug other than by administering, prescribing or dispensing. The
				  word "manufacture" has the same meaning as set forth in Mississippi Code,
				  Section
				  41-29-105(q).
Miss. Code Ann. §
										73-43-11
				  (1972, as amended).